PROXY STATEMENT

Company

TENAX THERAPEUTICS, INC.

Filed

August 12, 2014

Period of Report

September 11, 2014

Accession Number

0001354488-14-004097

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →